Literature DB >> 30428153

Robotic vs laparoscopic rectal tumour surgery: a cohort study.

D Asklid1, R Gerjy1, F Hjern2, K Pekkari1, U O Gustafsson1.   

Abstract

AIM: The aim of this study was to compare robotic and laparoscopic rectal surgery in terms of perioperative data, short-term outcome and compliance to the Enhanced Recovery After Surgery (ERAS) protocol.
METHOD: In this cohort study, 224 patients scheduled for rectal resection for cancer or adenoma between January 2011 and January 2017 were evaluated. In the first time period (12 January 2011 to 23 April 2014), 47 (46%) of 102 patients had laparoscopic surgery. In the second time period (24 April 2014 to 30 January 2017), 72 (59%) of 122 patients had robotic surgery. Perioperative data and short-term outcome were collected from the ERAS database and patient charts. Data obtained from laparoscopic and robotic surgery in the two time periods studied were compared. Primary outcome was hospital length of stay (LOS) and secondary outcomes were compliance to the ERAS protocol, difference in postoperative complications and conversion to open surgery.
RESULTS: Compliance to the ERAS protocol was 81.1% in the robotic group and 83.4% in the laparoscopic group (P = 0.890). Robotic surgery was associated with shorter median LOS (3 days vs 7 days, P < 0.001), lower conversion rate (11.1% vs 34.0%, P = 0.002), lower rate of postoperative complications (25% vs 49%, P < 0.01) and longer duration of surgery (5.8 h vs 4.5 h, P < 0.001). The differences remained after multivariate analysis.
CONCLUSION: Robotic surgery was associated with shorter LOS, lower conversion rates and fewer postoperative complications compared with laparoscopic surgery. Robotic surgery may add benefits to the ERAS protocol. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  zzm321990ERASzzm321990; Robotic rectal tumour surgery; Short-term outcome; laparoscopic rectal tumour surgery

Mesh:

Year:  2018        PMID: 30428153     DOI: 10.1111/codi.14475

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Robotic rectal cancer surgery with single side-docking technique: experience of a tertiary care university hospital.

Authors:  Thalia Petropoulou; Shwan Amin
Journal:  J Robot Surg       Date:  2020-05-08

2.  Predictors and Consequences of Unplanned Conversion to Open During Robotic Colectomy: An ACS-NSQIP Database Analysis.

Authors:  Andrew N Mueller; John D Vossler; Nicholas H Yim; Gregory J Harbison; Kenric M Murayama
Journal:  Hawaii J Health Soc Welf       Date:  2021-11

3.  The impact of robotic total mesorectal excision on survival of patients with rectal cancer-a propensity matched analysis.

Authors:  P Tejedor; F Sagias; K Flashman; Yeh Han Lee; S Naqvi; N Kandala; Jim Khan
Journal:  Int J Colorectal Dis       Date:  2019-11-11       Impact factor: 2.571

4.  Implementation of an enhanced recovery after surgery program with robotic surgery in high-risk patients obtains optimal results after colorectal resections.

Authors:  Lidia Cristóbal Poch; Carmen Cagigas Fernández; Marcos Gómez-Ruiz; Marta Ortega Roldán; Ramón Cantero Cid; Julio Castillo Diego; Manuel Gómez-Fleitas
Journal:  J Robot Surg       Date:  2021-07-18

5.  Combined robotic approach and enhanced recovery after surgery pathway for optimization of costs in patients undergoing proctectomy.

Authors:  P Rouanet; A Mermoud; M Jarlier; N Bouazza; A Laine; H Mathieu Daudé
Journal:  BJS Open       Date:  2020-04-30

Review 6.  Robotic-Assisted vs. Standard Laparoscopic Surgery for Rectal Cancer Resection: A Systematic Review and Meta-Analysis of 19,731 Patients.

Authors:  Kamil Safiejko; Radoslaw Tarkowski; Maciej Koselak; Marcin Juchimiuk; Aleksander Tarasik; Michal Pruc; Jacek Smereka; Lukasz Szarpak
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

7.  Short-term outcome in robotic vs laparoscopic and open rectal tumor surgery within an ERAS protocol: a retrospective cohort study from the Swedish ERAS database.

Authors:  Daniel Asklid; Olle Ljungqvist; Yin Xu; Ulf O Gustafsson
Journal:  Surg Endosc       Date:  2021-04-15       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.